Filing Details
- Accession Number:
- 0001127602-17-027344
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2017-09-12 17:33:25
- Reporting Period:
- 2017-09-11
- Accepted Time:
- 2017-09-12 17:33:25
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
64803 | Cvs Health Corp | CVS | Retail-Drug Stores And Proprietary Stores (5912) | 050494040 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1428718 | M David Denton | One Cvs Drive Woonsocket RI 02895- | Evp And Cfo | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2017-09-11 | 23,855 | $79.61 | 141,096 | No | 4 | S | Direct | |
Common Stock | Disposition | 2017-09-11 | 105,040 | $79.68 | 36,056 | No | 4 | S | Direct | |
Common Stock | Acquisiton | 2017-09-11 | 108,183 | $54.53 | 144,239 | No | 4 | M | Direct | |
Common Stock | Disposition | 2017-09-11 | 108,183 | $79.62 | 36,056 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Stock Option | Disposition | 2017-09-11 | 108,183 | $0.00 | 108,183 | $54.53 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
0 | 2014-04-01 | 2020-04-01 | No | 4 | M | Direct |
Reported Non-Derivative Holdings
Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
---|---|---|---|
Common Stock (Restricted) | 152,877 | Direct | |
Esop Common Stock | 1,710 | Indirect | By ESOP |
Reported Derivative Holdings
Sec. Name | Sec. Type | Price | Date | Expiration Date | Amount | Remaning Holdings | Nature of Ownership |
---|---|---|---|---|---|---|---|
Common Stock | Stock Option | $74.29 | 2015-04-01 | 2021-04-01 | 62,943 | 62,943 | Direct |
Common Stock | Stock Option | $102.26 | 2016-04-01 | 2022-04-01 | 59,922 | 59,922 | Direct |
Common Stock | Stock Option | $104.82 | 2017-04-01 | 2023-04-01 | 71,696 | 71,696 | Direct |
Common Stock | Stock Option | $78.05 | 2018-04-03 | 2024-04-03 | 100,179 | 100,179 | Direct |
Expiration Date | Amount | Remaning Holdings | Nature of Ownership |
---|---|---|---|
2021-04-01 | 62,943 | 62,943 | Direct |
2022-04-01 | 59,922 | 59,922 | Direct |
2023-04-01 | 71,696 | 71,696 | Direct |
2024-04-03 | 100,179 | 100,179 | Direct |
Footnotes
- All sales were effected pursuant to a Rule 10b5-1 plan.
- Represents weighted average sale price for this group of sales, which occurred on the same trading day. Multiple sales were executed, with sales prices ranging between $79.33 and $80.00 per share.
- Represents weighted average sale price for this group of sales, which occurred on the same trading day. Multiple sales were executed, with sales prices ranging between $79.35 and $80.00 per share.
- Represents weighted average sale price for this group of sales, which occurred on the same trading day. Multiple sales were executed, with sales prices ranging between $79.33 and $80.00 per share.
- Option became exercisable in four equal annual installments, commencing 4/1/2014.
- Option became exercisable in four equal annual installments, commencing 4/1/2015.
- Option became exercisable in four equal annual installments, commencing 4/1/2016.
- Option became exercisable in four equal annual installments, commencing 4/1/2017.
- Option becomes exercisable in four equal annual installments, commencing 4/3/2018.